4 Einträge gefunden

1. Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group

   1. Escherich, Gabriele
   2. Zur Stadt, Udo
   3. Borkhardt, Arndt
   4. Dilloo, Dagmar
   5. Faber, Jörg
   6. Feuchtinger, Tobias
   7. Imschweiler, Thomas

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Osteonecrosis develops independently from radiological leukemic infiltration of bone in adolescents with acute lymphoblastic leukemia - first findings of the OPAL trial

   1. Krull, Kathinka
   2. Kunstreich, Marina
   3. Klasen-Sansone, Janina
   4. Kloetgen, Andreas
   5. Gruener, Franziska
   6. Escherich, Gabriele
   7. Bleckmann, Kirsten

   2017 - Forschungsinformationssystem des UKE
3. The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).

   1. Escherich, Gabriele
   2. Troeger, Anja F
   3. Gobel, Ulrich
   4. Graubner, Ulrike
   5. Pekrun, Arnulf
   6. Jorch, Norbert
   7. Kaspers, Gjl

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
4. Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia.

   1. Graubner, Ulrike B
   2. Porzig, Simone
   3. Jorch, Norbert
   4. Kolb, Reinhard
   5. Wessalowski, Rüdiger
   6. Escherich, Gabriele
   7. Janka-Schaub, Gritta

   2008 - Forschungsinformationssystem des UKE